Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension-Reference-Cited by-同舟云学术

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

Published:2001-01 Issue:2 Volume:15 Page:427-438
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

TARASEVICIENE‐STEWART LAIMUTE¹,KASAHARA YASUNORI²,ALGER LORI¹,HIRTH PETER³,MAHON GERALD MC³,WALTENBERGER JOHANNES⁴,VOELKEL NORBERT F.²⁵,TUDER RUBIN M.¹⁵

Affiliation:

1. Department of PathologyDivision of Pulmonary Sciences and Critical Care MedicineUniversity of Colorado Health Sciences CenterDenverColorado80262USA

2. Department of MedicineDivision of Pulmonary Sciences and Critical Care MedicineUniversity of Colorado Health Sciences CenterDenverColorado80262USA

3. SUGENIncorporatedSouth San FranciscoCalifornia94080USA

4. Department of Internal Medicine II, CardiologyUlm University Medical CenterUlmD‐89081Germany

5. Pulmonary Hypertension CenterUniversity of Colorado Health Sciences CenterDenverColorado80262USA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.00-0343com

Reference32 articles.

1. Severe pulmonary hypertensive diseases: a perspective;Voelkel N. F.;Eur. Resp. J.,1999

2. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

3. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension;Tuder R. M.;Am. J. Pathol.,1994

4. Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific Markers

5. Primary Pulmonary Hypertension

Cited by 704 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STING Contributes to Pulmonary Hypertension by Targeting IFN and BMPR2 Signaling through Regulating of F2RL3;American Journal of Respiratory Cell and Molecular Biology;2024-09

2. Collagen 18A1/Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial Hypertension;American Journal of Respiratory Cell and Molecular Biology;2024-09

3. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension;Circulation;2024-08-06

4. Effectiveness of upfront triple oral combination therapy with additional pirfenidone in a patient with severe pulmonary hypertension associated with lung diseases;Respirology Case Reports;2024-08

5. UNRAVELING THE LUNG VASCULAR REMODELING IN PULMONARY HYPERTENSION USING A QUANTITATIVE DIGITAL PATHOLOGY SOFTWARE;2024-07-03